BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 26126449)

  • 1. Generation and Characterization of Patient-Specific iPSC Model for Cardiovascular Disease.
    Lee YK; Ran X; Lai KW; Lau VY; Siu DC; Tse HF
    Methods Mol Biol; 2016; 1353():191-213. PubMed ID: 26126449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of Cardiomyocytes from Pluripotent Stem Cells.
    Nakahama H; Di Pasquale E
    Methods Mol Biol; 2016; 1353():181-90. PubMed ID: 25523811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation and Neuronal Differentiation of Patient-Specific Induced Pluripotent Stem Cells Derived from Niemann-Pick Type C1 Fibroblasts.
    Trilck M; Hübner R; Frech MJ
    Methods Mol Biol; 2016; 1353():233-59. PubMed ID: 25520288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transgene-Free Disease-Specific iPSC Generation from Fibroblasts and Peripheral Blood Mononuclear Cells.
    Fidan K; Ebrahimi A; Çağlayan ÖH; Özçimen B; Önder TT
    Methods Mol Biol; 2016; 1353():215-31. PubMed ID: 26126451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-Specific Induced Pluripotent Stem Cell Models: Generation and Characterization of Cardiac Cells.
    Zanella F; Sheikh F
    Methods Mol Biol; 2016; 1353():147-62. PubMed ID: 25520292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of Human Pluripotent Stem Cells to Cardiomyocytes Under Defined Conditions.
    van den Berg CW; Elliott DA; Braam SR; Mummery CL; Davis RP
    Methods Mol Biol; 2016; 1353():163-80. PubMed ID: 25626427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial Disease-Specific Induced Pluripotent Stem Cell Models: Generation and Characterization.
    Zhang X; Li S; Yang W; Pan H; Qin D; Zhu X; Yan Q
    Methods Mol Biol; 2016; 1353():323-42. PubMed ID: 25646615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling Cardiovascular Diseases with Patient-Specific Human Pluripotent Stem Cell-Derived Cardiomyocytes.
    Burridge PW; Diecke S; Matsa E; Sharma A; Wu H; Wu JC
    Methods Mol Biol; 2016; 1353():119-30. PubMed ID: 25690476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defining optimal enzyme and matrix combination for replating of human induced pluripotent stem cell-derived cardiomyocytes at different levels of maturity.
    Koc A; Sahoglu Goktas S; Akgul Caglar T; Cagavi E
    Exp Cell Res; 2021 Jun; 403(2):112599. PubMed ID: 33848551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A universal system for highly efficient cardiac differentiation of human induced pluripotent stem cells that eliminates interline variability.
    Burridge PW; Thompson S; Millrod MA; Weinberg S; Yuan X; Peters A; Mahairaki V; Koliatsos VE; Tung L; Zambidis ET
    PLoS One; 2011 Apr; 6(4):e18293. PubMed ID: 21494607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancing Induced Pluripotent Stem Cell Generation by MicroRNA.
    Dang J; Rana TM
    Methods Mol Biol; 2016; 1357():71-84. PubMed ID: 25687299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cardiomyocyte differentiation of individual clones murine induced pluripotent stem cells].
    Malysheva SV; Budash HV; Bil'ko NM; Heschheller J
    Fiziol Zh (1994); 2013; 59(3):10-7. PubMed ID: 23957159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation and Characterization of Patient-Specific Induced Pluripotent Stem Cell for Disease Modeling.
    Sivapatham R; Zeng X
    Methods Mol Biol; 2016; 1353():25-44. PubMed ID: 25520284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inducing Pluripotency in Cattle.
    Malaver-Ortega LF; Taheri-Ghahfarokhi A; Sumer H
    Methods Mol Biol; 2015; 1330():57-68. PubMed ID: 26621589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vitro Modeling of Alcohol-Induced Liver Injury Using Human-Induced Pluripotent Stem Cells.
    Tian L; Prasad N; Jang YY
    Methods Mol Biol; 2016; 1353():271-83. PubMed ID: 25520290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using microRNAs to enhance the generation of induced pluripotent stem cells.
    Li Z; Rana TM
    Curr Protoc Stem Cell Biol; 2012; Chapter 4():Unit 4A.4. PubMed ID: 22415842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of Single Contracting Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Matrigel Mattress Technique.
    Cadar AG; Feaster TK; Durbin MD; Hong CC
    Curr Protoc Stem Cell Biol; 2017 Aug; 42():4A.14.1-4A.14.7. PubMed ID: 28806851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of clinical-grade human induced pluripotent stem cells in Xeno-free conditions.
    Wang J; Hao J; Bai D; Gu Q; Han W; Wang L; Tan Y; Li X; Xue K; Han P; Liu Z; Jia Y; Wu J; Liu L; Wang L; Li W; Liu Z; Zhou Q
    Stem Cell Res Ther; 2015 Nov; 6():223. PubMed ID: 26564165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling Axonal Phenotypes with Human Pluripotent Stem Cells.
    Denton KR; Xu CC; Li XJ
    Methods Mol Biol; 2016; 1353():309-21. PubMed ID: 25520289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A defined xeno-free and feeder-free culture system for the derivation, expansion and direct differentiation of transgene-free patient-specific induced pluripotent stem cells.
    Lu HF; Chai C; Lim TC; Leong MF; Lim JK; Gao S; Lim KL; Wan AC
    Biomaterials; 2014 Mar; 35(9):2816-26. PubMed ID: 24411336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.